Low circulating concentrations of citrulline and FGF19 predict chronic cholestasis and poor survival in adult patients with chronic intestinal failure: development of a Model for End-Stage Intestinal Failure (MESIF risk score)

Kiran V. K. Koelfat*, Angelique Huijbers, Frank G. Schaap, Sander M. J. van Kuijk, Martin Lenicek, Maarten R. Soeters, Geert J. A. Wanten, Steven W. M. Olde Damink

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1620-1629
Number of pages10
JournalAmerican Journal of Clinical Nutrition
Volume109
Issue number6
DOIs
Publication statusPublished - Jun 2019

Keywords

  • intestinal failure
  • chronic cholestasis
  • FGF19
  • citrulline
  • home parenteral nutrition
  • HOME PARENTERAL-NUTRITION
  • GROWTH-FACTOR 19
  • LIVER-DISEASE
  • PREVALENCE
  • DEPENDENCE
  • PLASMA
  • ACTIVATION
  • FIBROSIS
  • MARKER
  • PERIOD

Cite this